Lonza has launched its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

Leveraging cutting-edge continuous processing and proprietary clean & green technologies, STEERLife enables faster, greener and more efficient drug development. The company offers a complete ...

Sustainability-by-design in bioprocess development, according to Adam Goldstein, senior director of R&D Collaborations at ...

The API is, one might say, the most important element in a pharmaceutical product. Poor-quality APIs that do not meet potency ...

How important is it to understand the natural history of disease before embarking on drug development ... need can also help direct the development process. Understanding the disease for which ...

While significant progress has been made in developing treatments for rare diseases—highlighted by the approval of over 800 drugs for orphan diseases since ...

Viva Biotech's approach to drug discovery is grounded in the same core principle: a deep, structural understanding ... reducing downstream development risks and accelerating the overall antibody drug ...

Tinlarebant has previously been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug ...

Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative ...